A third dose of the COVID-19 vaccine that has been recommended for severely immunocompromised individuals aged 12 and older is now available to be accessed, says National Director COVID-19 Vaccination and Immunisation Programme Jo Gibbs. “Individuals who are severely immunocompromised are at a higher risk of severe outcomes from COVID-19 and might not produce a sufficiently strong immune response after two doses of the Pfizer COVID-19 vaccine.
A third primary dose may be beneficial and can be administered at least eight weeks after the second dose,” says Ms Gibbs. “The eligibility criteria to access a third primary dose is complex and applies to only the group of people who are severely immunocompromised. “Individuals who meet the